Medtronic, Inc.

Sims Deltec, Inc.

Other

Medtronics, Inc.

Pharmacia Deltec, Inc.

James M Olsen

Carl D Wahlstrand

Richard T Stone

Gregory Anthony Hrdlicka

Stephen L Bolea

Timothy R Abraham

Chad Qingshen Cai

Michael Robert Klardie

Thomas Barry Hoegh

Michael J Kern

Mark J Conroy

Michael T Hegland

Bruce R Mehdizadeh

Brian T Stolz

Spencer M Bondhus

Steven M Goetz

Robert M Skime

Gabriela C Molnar

Warren W Ball

Thomas E Cross, Jr

Spencer Fodness-Bondhus

James Grant Skakoon

Bryan D Stem

James Zimmerman

Robyn Lee Jagler

Jeffrey R Dixon

Hrishikesh Gadagkar

Timothy J Davis

Piotr J Przybyszewski

Jamu Alford

Mark S Lent

Jay Gregory Johnson

Jay K Lahti

Chris C Christiansen

John D Welter

Michael Kalm

Andrew J Ries

John E Kast

Mary M Morris

James A Alexander

Justin A Blanco

Spencer Fodness Bondhus

Jia Hu

Gary William King

Dale F Seeley

Jerome T Hartlaub

Thomas C Bischoff

Reginald D Robinson

Charles Randall Rogers

Gabriela C Miyazawa

Paula M Kaplan

Paul S Kratoska

Richard Dean Ries

Laetitia Mayor

Kristin J Malekkhosravi

Piotr Przybyszewski

Mark J Conway

Kristin J Schneider

Steve Christenson

Bryan S Stem

A shield located within an implantable medical lead may be terminated in various ways at a metal connector. The shield may be terminated by various joints including butt, scarf, lap, or other joints between insulation layers surrounding the lead and an insulation extension. The shield may terminate with a physical and electrical connection to a single metal connector. The shield may terminate with a physical and electrical connection by passing between an overlapping pair of inner and outer metal connectors. The metal connectors may include features such as teeth or threads that penetrate the insulation layers of the lead. The shield may terminate with a physical and electrical connection by exiting a jacket of a lead adjacent to a metal connector and lapping onto the metal connector.

Termination of a shield within an implantable medical lead

The disclosure is directed to programming implantable stimulators to deliver stimulation energy via one or more implantable leads having complex electrode array geometries. The disclosure also contemplates guided programming to select electrode combinations and parameter values to support efficacy. The techniques may be applied to a programming interface associated with a clinician programmer, a patient programmer, or both. A user interface permits a user to view electrodes from different perspectives relative to the lead. For example, the user interface provides a side view of a lead and a cross-sectional view of the lead. The user interface may include an axial control medium to select and/or view electrodes at different axial positions along the length of a lead, and a rotational control medium to select and/or view electrodes at different angular positions around a circumference of the lead.

Unwrapped 2D view of a stimulation lead with complex electrode array geometry

Conductors within an implantable medical lead that carry stimulation signal signals are at least partially embedded within a lead body of the medical lead over at least a portion of the length of the conductors while being surrounded by a radio frequency (RF) shield. A space between the shield and the conductors is filled by the presence of the lead body material such that body fluids that infiltrate the lead over time cannot pool in the space between the shield and the conductors. The dielectric properties of the lead body are retained and the capacitive coupling between the shield and the conductors continues to be inhibited such that current induced on the shield is inhibited from being channeled onto the conductors. Heating at the electrodes of the medical lead is prevented from becoming excessive.

Devices, systems and methods to reduce coupling of a conductor within an implantable medical lead

A shield layer is added to an existing lead or lead extension by applying the shield layer to the lead body between the proximal contact and distal electrode of the lead body. The shield layer may be covered with an outer insulative layer. An inner insulative layer may be applied over the lead body prior to adding the shield layer and the outer insulative layer. The shield layer may have a terminator applied to the end of the shield layer to prevent migration of the shield layer through the outer insulative layer. The shield layer may be of various forms including a tubular braided wire structure or a tubular foil. The tubular braided wire structure may be applied to the lead body by utilizing the lead body as a mandrel within a braiding machine.

Methods of shielding implantable medical leads and implantable medical lead extensions

A shield located within an implantable medical lead may be terminated in various ways. The shield may be terminated by butt, scarf, lap, or other joints between insulation layers surrounding the lead and an insulation extension. For lap joints, a portion of an outer insulation layer may be removed and a replacement outer insulation layer is positioned in place of the removed outer insulation layer, where the replacement layer extends beyond an inner insulation layer and the shield. The replacement layer may also lap onto a portion of the insulation extension. The barbs may be located between the replacement layer and the inner insulation layer or the insulation extension. The shield wires have ends at the termination point that may be folded over individually or may be capped with a ring located within one of the insulation layers of the jacket.

Radiopaque markers represent that a lead is suitable for a particular medical procedure such as a magnetic resonance image scan and are added to the lead or related device. The markers may be added after implantation of the lead in various ways including suturing, gluing, crimping, or clamping a radiopaque tag to the lead or to the device. The markers may be added by placing a radiopaque coil about the lead, and the radiopaque coil may radially contract against the lead to obtain a fixed position. The markers may be added by placing a polymer structure onto the lead where the polymer structure includes a radiopaque marker within it. The polymer structure may include a cylindrical aperture that contracts against the lead to fix the position of the polymer structure. The polymer structure may form a lead anchor that includes suture wings that can be sutured to the lead.

Radiopaque markers for implantable medical leads, devices, and systems

Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead

Changes in electrical stimulation therapy delivered via a medical device are coordinated with Functional Magnetic Resonance Imaging (fMRI) scans. In one example, a medical device delivers electrical stimulation therapy to a patient in an MRI unit, where the medical device is configured to cycle electrical stimulation therapy between a plurality of stimulation states. An indication that the medical device will cycle the electrical stimulation therapy or has cycled the electrical stimulation therapy while the patient is in the MRI unit or being imaged by the MRI unit is generated, and an MRI scan of the patient via an MRI workstation is initiated based on the indication. In another example, a medical device detects activation of an MRI scan and automatically switches stimulation states based upon the detection of the MRI scan, such that the scan is associated with a particular stimulation state.

Coordination of functional MRI scanning and electrical stimulation therapy

Implantable medical leads and implantable lead extensions include a shield. The implantable medical lead is coupled to the implantable lead extension. Stimulation electrodes of the implantable medical lead contact stimulation connectors within a housing of the implantable extension to establish a conductive pathway for stimulation signals from filars of the implantable extension to filars of the implantable medical lead. Continuity is established between the shield of the implantable medical lead and the implantable extension by providing a radio frequency conductive pathway within the housing. The radio frequency conductive pathway extends from a shield of the implantable extension to a shield connector that contacts a shield electrode of the implantable medical lead. The radio frequency conductive pathway may have various forms such as a jumper wire or an extension of the shield within the implantable extension.

Establishing continuity between a shield within an implantable medical lead and a shield within an implantable lead extension

A shield located within an implantable medical lead may be terminated in various ways. The shield may be terminated by butt, scarf, lap, or other joints between insulation layers surrounding the lead and an insulation extension. For lap joints, a portion of an outer insulation layer may be removed and a replacement outer insulation layer is positioned in place of the removed outer insulation layer, where the replacement layer extends beyond an inner insulation layer and the shield. The replacement layer may also lap onto a portion of the insulation extension. Barbs may be located between the replacement layer and the inner insulation layer or the insulation extension. The shield wires have ends at the termination point that may be folded over individually or may be capped with a ring located within one of the insulation layers of the jacket.

Growing community of inventors

Plymouth, MN, United States of America

James M Olsen